Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells
Secreted proteins present a rich resource of potential cancer biomarkers. Here, the authors use mass spectrometry to analyze secretome remodeling in pulmonary neuroendocrine lung cancer cell lines and validate potential biomarkers and therapeutic targets in vitro and in mouse models.
Guardado en:
Autores principales: | Xu-Dong Wang, Rongkuan Hu, Qing Ding, Trisha K. Savage, Kenneth E. Huffman, Noelle Williams, Melanie H. Cobb, John D. Minna, Jane E. Johnson, Yonghao Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab493e2c25ce4d6f9e28ead2e5b28542 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
por: Paloma Cejas, et al.
Publicado: (2021) -
Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer
por: Ling Cai, et al.
Publicado: (2021) -
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
por: Phuong-Uyen C. Dinh, et al.
Publicado: (2020) -
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
por: Julie George, et al.
Publicado: (2018) -
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes
por: Christina M. Bebber, et al.
Publicado: (2021)